Free Trial

Xylem (XYL) Stock Forecast & Price Target

$136.69
-4.03 (-2.86%)
(As of 07/24/2024 ET)

Xylem - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 14 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for XYL.

Consensus Price Target

$144.58
5.77% Upside
High Forecast$170.00
Average Forecast$144.58
Low Forecast$120.00

According to the 14 analysts' twelve-month price targets for Xylem, the average price target is $144.58. The highest price target for XYL is $170.00, while the lowest price target for XYL is $120.00. The average price target represents a forecasted upside of 5.77% from the current price of $136.69.

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$144.58$142.92$138.11$117.00
Forecasted Upside5.77% Upside14.40% Upside17.42% Upside9.89% Upside
Get Xylem Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for XYL and its competitors with MarketBeat's FREE daily newsletter.

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xylem Stock vs. The Competition

TypeXylemIndustrial Products CompaniesS&P 500
Consensus Rating Score
2.71
2.54
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside5.77% Upside41.68% Upside10.61% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/18/2024Stifel Nicolaus
4 of 5 stars
 Boost TargetBuy ➝ Buy$157.00 ➝ $170.00+22.85%
6/6/2024TD Cowen
4 of 5 stars
 Boost TargetBuy ➝ Buy$135.00 ➝ $138.00+0.71%
5/31/2024Oppenheimer
3 of 5 stars
 Boost TargetOutperform ➝ Outperform$147.00 ➝ $152.00+9.71%
5/29/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$146.00 ➝ $165.00+19.75%
5/3/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$157.00 ➝ $162.00+18.28%
5/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$110.00 ➝ $135.00-0.73%
5/3/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$151.00 ➝ $155.00+13.98%
4/8/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$126.00 ➝ $139.00+8.81%
3/12/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$150.00+18.88%
1/4/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$127.00+17.66%
11/21/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$104.00 ➝ $120.00+19.74%
10/2/2023Melius
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$122.00+33.46%
8/29/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Graham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
6/29/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
2/14/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joseph C Giordano
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$115.00 ➝ $120.00+11.99%
1/18/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$105.00 ➝ $115.00-0.86%
11/16/2022Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$110.00 ➝ $129.00+15.05%
11/3/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$85.00 ➝ $95.00-11.78%
11/2/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$105.00 ➝ $115.00+7.35%
11/2/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$93.00 ➝ $110.00+4.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:07 PM ET.

XYL Forecast - Frequently Asked Questions

What is Xylem's forecast for 2024?

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $144.58, with a high forecast of $170.00 and a low forecast of $120.00.

Should I buy or sell Xylem stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" XYL shares.

Does Xylem's stock price have much upside?

According to analysts, Xylem's stock has a predicted upside of 14.58% based on their 12-month stock forecasts.

What analysts cover Xylem?

Xylem has been rated by research analysts at Argus, Mizuho, Oppenheimer, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, and TD Cowen in the past 90 days.

Do Wall Street analysts like Xylem more than its competitors?

Analysts like Xylem more than other "industrial products" companies. The consensus rating score for Xylem is 2.71 while the average consensus rating score for "industrial products" companies is 2.54. Learn more on how XYL compares to other companies.


This page (NYSE:XYL) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners